A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia Meeting Abstract
| Authors: | Heinrich, M. C.; Druker, B. J.; Curtin, P. T.; Paquette, R.; Sawyers, C. L.; De Angelo, D. J.; Gilliland, G. D.; Stone, R. M.; Caliguiri, M. A.; Byrd, J. C.; Heaney, M. L.; Nimer, S. D.; Romanko, K. P.; Lambing, J. L.; Lokker, N. A.; Giese, N. A.; Gretler, D. D. |
| Abstract Title: | A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia |
| Meeting Title: | 44th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 100 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2002 Dec 6-10 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2002-11-01 |
| Start Page: | 336A |
| End Page: | 337A |
| Language: | English |
| ACCESSION: | WOS:000179184701305 |
| PROVIDER: | wos |
| PUBMED: | 12448415 |
| Notes: | Meeting Abstract: 1305 -- 44th Annual Meeting of the American-Society-of-Hematology -- DEC 06-10, 2002 -- PHILADELPHIA, PENNSYLVANIA -- 1 -- Source: Wos |
